Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 5/20 | 0.55 |
| ▸ | GNB1 | P62873 | 5/20 | 0.55 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.55 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | NSD2 | O96028 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12974455 | 0.91 | PHLPP2 (0.55) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL8021024 | 0.85 | GNG2 (0.64) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL14355357 | 0.84 | GNG2 (0.62) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL18493688 | 0.80 | GNG2 (0.60) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL8632381 | 0.80 | GNG2 (0.57) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL9844573 | 0.80 | GNG2 (0.61) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL12172884 | 0.79 | GNG2 (0.61) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL11319865 | 0.79 | GNG2 (0.64) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL11249954 | 0.79 | PHLPP2 (0.49) | GNG2GNB1PHLPP2P2RY4ALDH1A1 | |
| SCHEMBL30371545 | 0.79 | GNG2 (0.60) | GNG2GNB1PHLPP2P2RY4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | GNG2 937/4885GNB1 890/4885PHLPP2 1070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.